In our cohort, immunohistochemical INI1 (SMARCB1) deficient thoracic neoplasms occurred in one woman and eight men, ranging from 20 to 76 years of age (mean 57 years) at disease presentation. This evidence concerns the gene SMARCB1 and neoplasm of thorax.